LeonaBio, Inc. LONA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-18
LeonaBio, Inc. statistics & valuation
Market cap$88.3M
P / B3.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -114.6% | -164.9% | -73.4% | -37.0% | -16.5% |
| Return on equity | -380.0% | -216.2% | -90.4% | -40.7% | -17.1% |
| Current ratio | 1.88 | 4.18 | 5.37 | 9.68 | 28.07 |
Source: SEC EDGAR filings · CIK 0001620463 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.